Diamonds and Dogs

12/1/17

Mylan (MYL) in Amazon's crosshairs? The generic drug maker rose 4% today after gaining FDA approval for a generic blood thinner drug. The stock also got a lift from rumors Amazon has held 'exploratory talks' with generic-drug makers including Mylan. I guess that is the next logical step for Amazon in their quest for world domination.

Chip stocks took it on the chin. After rallying over 40% year to date, the chip sector took it on the chin this week. Micron (MU) fell a percent today and 15% for the week. NVidia (NVDA) fell a percent today and 9% for the week. Broadcom (AVGO) and Qualcomm both dropped over a 1% as any possible takeover has been delayed until the New Year.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.